As a leading manufacturer of advanced adhesive solutions for the medical industry, Henkel has launched a novel medical grade lightcure adhesive designed for devices that are to be worn on the body. The new product is formulated without IBOA (Isobornyl Acrylate) or any other known skin sensitizing monomers. The adhesive is also formulated to conform to EU MDR 2017 regulations concerning use of CMR (carcinogenic, mutagenic, or toxic for reproduction) substances in medical devices making it a robust option for new designs.

The newly developed adhesive is available in two different grades. Loctite WT 3001 and Loctite WT 3003 have both been tested according to ISO 10993 standards, ensuring a high level of safety and performance for users. The solutions have also been tested for skin sensitization, making them suitable for a wide range of medical applications including wearable devices.

With the increasing demand for medical devices and wearables, the need for safe and reliable adhesive solutions is crucial. Henkel’s new wearable device light-cure adhesive provides an excellent bonding solution for medical devices, ensuring strong and durable connections while remaining free of known skin sensitizing monomers such as IBOA, which is known to cause patient skin reactions when used in wearables.

“With the introduction of our new medical grade wearable device light-cure adhesive, we are addressing the growing need for safe and effective adhesives in the medical industry. Our adhesive is ISO 10993 tested and formulated with patient comfort and safety in mind, ensuring its suitability for use in medical device bonding and medical wearables,” said Philipp Loosen, Vice President and Head of Industrials EIMEA and Global Key Accounts Medical at Henkel.

Henkel’s wearable device light-cure adhesive offers various benefits for medical applications. Its light-cure capabilities allow for quick and efficient bonding, reducing production time and increasing productivity. The adhesive also provides excellent adhesion to a wide range of substrates commonly used in medical devices and wearables, ensuring robust bonding and sealing performance after drop impact or bathing.

Furthermore, the adhesive’s formulation meets FDA & EU MDR recommendations for wearable medical devices regarding sensitizing and CMR ingredients. The focus on removing all known skin sensitizing monomers further reduces the risk of skin sensitization making the adhesive suitable for prolonged skin contact in medical applications.

Loctite WT 3001 and Loctite WT 3003 are new medical grade light-cure adhesives for housing, sealing and bonding applications and have been tested according to the ISO10993 protocol.